|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,730.00 KRW | -0.39% |
|
+4.95% | -5.84% |
| 06-13 | Shinpoong Pharmaceutical Co.,Ltd(KOSE:A019170) dropped from KOSPI 200 Index | CI |
| 04-24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Enjoy this offer
* See conditions on site
| Capitalization | 667B 502M 682M | P/E ratio 2022 |
-31.9x | P/E ratio 2023 | -12.6x |
|---|---|---|---|---|---|
| Enterprise value | 653B 491M 668M | EV / Sales 2022 |
5.12x | EV / Sales 2023 | 3.46x |
| Free-Float |
58.9% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | -0.39% | ||
| 1 week | +4.95% | ||
| Current month | -3.92% | ||
| 1 month | -19.58% | ||
| 3 months | +7.43% | ||
| 6 months | +7.25% | ||
| Current year | -5.84% |
1 week
11 800.00
12 820.00
1 month
11 800.0019 750.00
Current year
10 100.0019 850.00
1 year
9 560.0019 850.00
3 years
9 560.0067 900.00
5 years
5 800.00214 000.00
10 years
3 653.82214 000.00
| Director | Title | Age | Since |
|---|---|---|---|
Je-Man Yoo
CEO | Chief Executive Officer | 67 | 14-03-20 |
Jin-Gyu Park
DFI | Director of Finance/CFO | 59 | - |
Chung Joo
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Hyun-Jae Cho
BRD | Director/Board Member | 53 | 13-03-28 |
Je-Man Yoo
CEO | Chief Executive Officer | 67 | 14-03-20 |
Seung-Chul Han
BRD | Director/Board Member | 61 | 18-03-29 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 99 M€ | +5.11% | - | |
| 0.00% | 7 M€ | +7.58% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.39% | +4.95% | -23.95% | -81.06% | 500M | ||
| -0.62% | +1.60% | +61.37% | +137.57% | 53.32B | ||
| -2.01% | -1.82% | +48.26% | +62.33% | 31.15B | ||
| +0.14% | -1.76% | - | - | 17.7B | ||
| +0.15% | +3.02% | +35.10% | +74.62% | 15.94B | ||
| -0.14% | +1.69% | +73.89% | +101.34% | 13.43B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| -1.09% | -5.33% | -33.58% | -29.35% | 6.37B | ||
| +0.33% | +3.00% | +103.47% | +238.10% | 5.88B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| Average | -0.36% | -0.01% | +37.79% | +71.94% | 15.68B | |
| Weighted average by Cap. | -0.62% | +0.36% | +53.01% | +102.69% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 209B 158M 214M | 200B 151M 205M |
| Net income | -35.38B -26.64M -36.19M | -57.33B -43.17M -58.64M |
| Net Debt | -53.99B -40.65M -55.23M | -14.43B -10.87M -14.76M |
More financial data
* Estimated data
Employees
828
Sector
Pharmaceuticals
Calendar
2024-11-12
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-13 | 12,730.00 ₩ | -0.39% | 94,520 |
| 24-09-12 | 12,780.00 ₩ | +1.51% | 142,126 |
| 24-09-11 | 12,590.00 ₩ | +2.44% | 202,918 |
| 24-09-10 | 12,290.00 ₩ | -0.08% | 188,921 |
| 24-09-09 | 12,300.00 ₩ | +1.40% | 169,272 |
End-of-day quote Korea S.E., September 12, 2024
More quotes- Stock Market
- Equities
- A019170 Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition